Package 27808-223-01

Brand: paliperidone

Generic: paliperidone
NDC Package

Package Facts

Identity

Package NDC 27808-223-01
Digits Only 2780822301
Product NDC 27808-223
Product ID 27808-223_ffd2bfbd-11f5-436a-9ebf-bbd4ef92bacd
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27808-223-01)

Marketing

Marketing Status
Marketed Since 2021-10-25
Brand paliperidone
Generic paliperidone
Sample Package No

Linked Drug Pages (1)

Paliperidone ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ffd2bfbd-11f5-436a-9ebf-bbd4ef92bacd", "openfda": {"nui": ["N0000175430"], "unii": ["838F01T721"], "rxcui": ["672567", "672569", "672571", "866103"], "spl_set_id": ["d7033e52-3df2-48e2-adda-15a57c2f148f"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Tris Pharma Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27808-223-01)", "package_ndc": "27808-223-01", "marketing_start_date": "20211025"}], "brand_name": "Paliperidone", "product_id": "27808-223_ffd2bfbd-11f5-436a-9ebf-bbd4ef92bacd", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "27808-223", "generic_name": "paliperidone", "labeler_name": "Tris Pharma Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Paliperidone", "active_ingredients": [{"name": "PALIPERIDONE", "strength": "3 mg/1"}], "application_number": "ANDA212807", "marketing_category": "ANDA", "marketing_start_date": "20201029", "listing_expiration_date": "20261231"}